CWGCX
Price
$60.21
Change
+$0.11 (+0.18%)
Updated
Apr 17 closing price
Net Assets
117.17B
MSFBX
Price
$32.20
Change
-$0.18 (-0.56%)
Updated
Apr 17 closing price
Net Assets
2.56B
Ad is loading...

CWGCX vs MSFBX

Header iconCWGCX vs MSFBX Comparison
Open Charts CWGCX vs MSFBXBanner chart's image
American Funds Capital World Gr&Inc C
Price$60.21
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets117.17B
Morgan Stanley Inst Global Franchise A
Price$32.20
Change-$0.18 (-0.56%)
VolumeN/A
Net Assets2.56B
CWGCX vs MSFBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. MSFBX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and MSFBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 117B vs. MSFBX (2.56B). CWGCX pays higher dividends than MSFBX: CWGCX (0.93) vs MSFBX (0.43). CWGCX was incepted earlier than MSFBX: CWGCX (24 years) vs MSFBX (23 years). CWGCX (1.49) is less costly to investors than MSFBX (1.17). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MSFBX (15.00). CWGCX has a lower initial minimum investment than MSFBX: CWGCX (250) vs MSFBX (1000). MSFBX annual gain was more profitable for investors over the last year : -0.87 vs. CWGCX (-1.68). CWGCX return over 5 years is better than : 40.10 vs. MSFBX (27.04).
CWGCXMSFBXCWGCX / MSFBX
Total Expense Ratio1.491.17127%
Annual Report Gross Expense Ratio1.491.17127%
Fund Existence24 years23 years-
Gain YTD-3.9130.552-708%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B2.56B4,563%
Annual Yield % from dividends0.930.43214%
Returns for 1 year-1.68-0.87194%
Returns for 3 years9.073.12291%
Returns for 5 years40.1027.04148%
Returns for 10 years29.5063.1347%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLAX31.13N/A
N/A
PGIM Jennison Health Sciences A
LGPSX31.33N/A
N/A
ProFunds Large Cap Growth Svc
PRJQX40.63N/A
N/A
PGIM Jennison Global Opportunities R6
MNBRX18.86N/A
N/A
Manning & Napier Pro-Blend Extnd Term R
CEIZX11.82N/A
N/A
Manning & Napier Callodine Equity Inc Z